All tenders
75F40120C00179
BAA: QUANTIFYING PATIENTS' BENEFIT-RISK TRADEOFFS ASSOCIATED WITH PERCUTANEOUS REVASCULARIZATION OPTIONS FOR PERIPHERAL ARTERIAL DISEASE: A COLLABORATIVE EFFORT WITH THE RAPID PATHWAYS PATIENT SCIENCE WORKING GROUP
Food and Drug Administration · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedEducation & TrainingFederal
Basic information
- Reference number
- 75F40120C00179
- Issuing organization
- Food and Drug Administration · Find award history →
- Government level
- Federal
- Solicitation type
- Education & Training
- Title
- BAA: QUANTIFYING PATIENTS' BENEFIT-RISK TRADEOFFS ASSOCIATED WITH PERCUTANEOUS REVASCULARIZATION OPTIONS FOR PERIPHERAL ARTERIAL DISEASE: A COLLABORATIVE EFFORT WITH THE RAPID PATHWAYS PATIENT SCIENCE WORKING GROUP
- Source
- USASpending (Federal)
- Source ID
- usa-75F40120C00179
Details
- Location
- United States
Description
BAA: QUANTIFYING PATIENTS' BENEFIT-RISK TRADEOFFS ASSOCIATED WITH PERCUTANEOUS REVASCULARIZATION OPTIONS FOR PERIPHERAL ARTERIAL DISEASE: A COLLABORATIVE EFFORT WITH THE RAPID PATHWAYS PATIENT SCIENCE WORKING GROUP Awarded to: DUKE UNIVERSITY Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2020/09/25 12:00:00 AM UTC
- Closing date
- 2024/06/30 12:00:00 AM UTC
Estimated value
$1.4M USD
Classification
Normalized category
Education & Training